China Disease Control and Prevention Vaccine Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Vaccines are biological entity used to activate acquired immunity to control or prevent particular disease or a group of disease. Immunization is carried out in infants as well as in adults. Vaccination against various bacterial and viral diseases is an integral part of infectious disease control world-wide.

    This report offers an overview of the market trends, drivers, and barriers with respect to the China Disease Control and Prevention Vaccine market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Disease Control and Prevention Vaccine market. Detailed analysis of key players, along with key growth strategies adopted by Disease Control and Prevention Vaccine industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Sanofi

    • Pfizer

    • AstraZeneca PLC

    • Astellas Pharma Inc

    • Sinovac Biotech Ltd

    • Daiichi Sankyo

    • GSK

    By Type:

    • Live-Attenuated

    • Inactivated

    • Recombinant Sub Unit and Toxoid

    By End-User:

    • Pediatric Vaccine

    • Adult Vaccine

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Disease Control and Prevention Vaccine Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Disease Control and Prevention Vaccine Market Size and Growth Rate of Live-Attenuated from 2016 to 2027

    • 1.3.2 China Disease Control and Prevention Vaccine Market Size and Growth Rate of Inactivated from 2016 to 2027

    • 1.3.3 China Disease Control and Prevention Vaccine Market Size and Growth Rate of Recombinant Sub Unit and Toxoid from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Disease Control and Prevention Vaccine Market Size and Growth Rate of Pediatric Vaccine from 2016 to 2027

    • 1.4.2 China Disease Control and Prevention Vaccine Market Size and Growth Rate of Adult Vaccine from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Disease Control and Prevention Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Disease Control and Prevention Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Disease Control and Prevention Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Disease Control and Prevention Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Disease Control and Prevention Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Disease Control and Prevention Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Disease Control and Prevention Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Disease Control and Prevention Vaccine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Disease Control and Prevention Vaccine by Major Types

    • 3.4.1 Market Size and Growth Rate of Live-Attenuated

    • 3.4.2 Market Size and Growth Rate of Inactivated

    • 3.4.3 Market Size and Growth Rate of Recombinant Sub Unit and Toxoid

    4 Segmentation of Disease Control and Prevention Vaccine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Disease Control and Prevention Vaccine by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Disease Control and Prevention Vaccine in Pediatric Vaccine

    • 4.4.2 Market Size and Growth Rate of Disease Control and Prevention Vaccine in Adult Vaccine

    5 Market Analysis by Regions

    • 5.1 China Disease Control and Prevention Vaccine Production Analysis by Regions

    • 5.2 China Disease Control and Prevention Vaccine Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Disease Control and Prevention Vaccine Landscape Analysis

    • 6.1 North China Disease Control and Prevention Vaccine Landscape Analysis by Major Types

    • 6.2 North China Disease Control and Prevention Vaccine Landscape Analysis by Major End-Users

    7 Central China Disease Control and Prevention Vaccine Landscape Analysis

    • 7.1 Central China Disease Control and Prevention Vaccine Landscape Analysis by Major Types

    • 7.2 Central China Disease Control and Prevention Vaccine Landscape Analysis by Major End-Users

    8 South China Disease Control and Prevention Vaccine Landscape Analysis

    • 8.1 South China Disease Control and Prevention Vaccine Landscape Analysis by Major Types

    • 8.2 South China Disease Control and Prevention Vaccine Landscape Analysis by Major End-Users

    9 East China Disease Control and Prevention Vaccine Landscape Analysis

    • 9.1 East China Disease Control and Prevention Vaccine Landscape Analysis by Major Types

    • 9.2 East China Disease Control and Prevention Vaccine Landscape Analysis by Major End-Users

    10 Northeast China Disease Control and Prevention Vaccine Landscape Analysis

    • 10.1 Northeast China Disease Control and Prevention Vaccine Landscape Analysis by Major Types

    • 10.2 Northeast China Disease Control and Prevention Vaccine Landscape Analysis by Major End-Users

    11 Southwest China Disease Control and Prevention Vaccine Landscape Analysis

    • 11.1 Southwest China Disease Control and Prevention Vaccine Landscape Analysis by Major Types

    • 11.2 Southwest China Disease Control and Prevention Vaccine Landscape Analysis by Major End-Users

    12 Northwest China Disease Control and Prevention Vaccine Landscape Analysis

    • 12.1 Northwest China Disease Control and Prevention Vaccine Landscape Analysis by Major Types

    • 12.2 Northwest China Disease Control and Prevention Vaccine Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Sanofi

      • 13.1.1 Sanofi Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Pfizer

      • 13.2.1 Pfizer Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 AstraZeneca PLC

      • 13.3.1 AstraZeneca PLC Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Astellas Pharma Inc

      • 13.4.1 Astellas Pharma Inc Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Sinovac Biotech Ltd

      • 13.5.1 Sinovac Biotech Ltd Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Daiichi Sankyo

      • 13.6.1 Daiichi Sankyo Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 GSK

      • 13.7.1 GSK Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Disease Control and Prevention Vaccine Market Size and Growth Rate of Live-Attenuated from 2016 to 2027

    • Figure China Disease Control and Prevention Vaccine Market Size and Growth Rate of Inactivated from 2016 to 2027

    • Figure China Disease Control and Prevention Vaccine Market Size and Growth Rate of Recombinant Sub Unit and Toxoid from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Disease Control and Prevention Vaccine Market Size and Growth Rate of Pediatric Vaccine from 2016 to 2027

    • Figure China Disease Control and Prevention Vaccine Market Size and Growth Rate of Adult Vaccine from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Disease Control and Prevention Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Disease Control and Prevention Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Disease Control and Prevention Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Disease Control and Prevention Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Disease Control and Prevention Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Disease Control and Prevention Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Disease Control and Prevention Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Disease Control and Prevention Vaccine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Disease Control and Prevention Vaccine

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Disease Control and Prevention Vaccine by Different Types from 2016 to 2027

    • Table Consumption Share of Disease Control and Prevention Vaccine by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Live-Attenuated

    • Figure Market Size and Growth Rate of Inactivated

    • Figure Market Size and Growth Rate of Recombinant Sub Unit and Toxoid

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Disease Control and Prevention Vaccine by Different End-Users from 2016 to 2027

    • Table Consumption Share of Disease Control and Prevention Vaccine by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Pediatric Vaccine

    • Figure Market Size and Growth Rate of Adult Vaccine

    • Table China Disease Control and Prevention Vaccine Production by Regions

    • Table China Disease Control and Prevention Vaccine Production Share by Regions

    • Figure China Disease Control and Prevention Vaccine Production Share by Regions in 2016

    • Figure China Disease Control and Prevention Vaccine Production Share by Regions in 2021

    • Figure China Disease Control and Prevention Vaccine Production Share by Regions in 2027

    • Table China Disease Control and Prevention Vaccine Consumption by Regions

    • Table China Disease Control and Prevention Vaccine Consumption Share by Regions

    • Figure China Disease Control and Prevention Vaccine Consumption Share by Regions in 2016

    • Figure China Disease Control and Prevention Vaccine Consumption Share by Regions in 2021

    • Figure China Disease Control and Prevention Vaccine Consumption Share by Regions in 2027

    • Table North China Disease Control and Prevention Vaccine Consumption by Types from 2016 to 2027

    • Table North China Disease Control and Prevention Vaccine Consumption Share by Types from 2016 to 2027

    • Figure North China Disease Control and Prevention Vaccine Consumption Share by Types in 2016

    • Figure North China Disease Control and Prevention Vaccine Consumption Share by Types in 2021

    • Figure North China Disease Control and Prevention Vaccine Consumption Share by Types in 2027

    • Table North China Disease Control and Prevention Vaccine Consumption by End-Users from 2016 to 2027

    • Table North China Disease Control and Prevention Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure North China Disease Control and Prevention Vaccine Consumption Share by End-Users in 2016

    • Figure North China Disease Control and Prevention Vaccine Consumption Share by End-Users in 2021

    • Figure North China Disease Control and Prevention Vaccine Consumption Share by End-Users in 2027

    • Table Central China Disease Control and Prevention Vaccine Consumption by Types from 2016 to 2027

    • Table Central China Disease Control and Prevention Vaccine Consumption Share by Types from 2016 to 2027

    • Figure Central China Disease Control and Prevention Vaccine Consumption Share by Types in 2016

    • Figure Central China Disease Control and Prevention Vaccine Consumption Share by Types in 2021

    • Figure Central China Disease Control and Prevention Vaccine Consumption Share by Types in 2027

    • Table Central China Disease Control and Prevention Vaccine Consumption by End-Users from 2016 to 2027

    • Table Central China Disease Control and Prevention Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Disease Control and Prevention Vaccine Consumption Share by End-Users in 2016

    • Figure Central China Disease Control and Prevention Vaccine Consumption Share by End-Users in 2021

    • Figure Central China Disease Control and Prevention Vaccine Consumption Share by End-Users in 2027

    • Table South China Disease Control and Prevention Vaccine Consumption by Types from 2016 to 2027

    • Table South China Disease Control and Prevention Vaccine Consumption Share by Types from 2016 to 2027

    • Figure South China Disease Control and Prevention Vaccine Consumption Share by Types in 2016

    • Figure South China Disease Control and Prevention Vaccine Consumption Share by Types in 2021

    • Figure South China Disease Control and Prevention Vaccine Consumption Share by Types in 2027

    • Table South China Disease Control and Prevention Vaccine Consumption by End-Users from 2016 to 2027

    • Table South China Disease Control and Prevention Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure South China Disease Control and Prevention Vaccine Consumption Share by End-Users in 2016

    • Figure South China Disease Control and Prevention Vaccine Consumption Share by End-Users in 2021

    • Figure South China Disease Control and Prevention Vaccine Consumption Share by End-Users in 2027

    • Table East China Disease Control and Prevention Vaccine Consumption by Types from 2016 to 2027

    • Table East China Disease Control and Prevention Vaccine Consumption Share by Types from 2016 to 2027

    • Figure East China Disease Control and Prevention Vaccine Consumption Share by Types in 2016

    • Figure East China Disease Control and Prevention Vaccine Consumption Share by Types in 2021

    • Figure East China Disease Control and Prevention Vaccine Consumption Share by Types in 2027

    • Table East China Disease Control and Prevention Vaccine Consumption by End-Users from 2016 to 2027

    • Table East China Disease Control and Prevention Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure East China Disease Control and Prevention Vaccine Consumption Share by End-Users in 2016

    • Figure East China Disease Control and Prevention Vaccine Consumption Share by End-Users in 2021

    • Figure East China Disease Control and Prevention Vaccine Consumption Share by End-Users in 2027

    • Table Northeast China Disease Control and Prevention Vaccine Consumption by Types from 2016 to 2027

    • Table Northeast China Disease Control and Prevention Vaccine Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Disease Control and Prevention Vaccine Consumption Share by Types in 2016

    • Figure Northeast China Disease Control and Prevention Vaccine Consumption Share by Types in 2021

    • Figure Northeast China Disease Control and Prevention Vaccine Consumption Share by Types in 2027

    • Table Northeast China Disease Control and Prevention Vaccine Consumption by End-Users from 2016 to 2027

    • Table Northeast China Disease Control and Prevention Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Disease Control and Prevention Vaccine Consumption Share by End-Users in 2016

    • Figure Northeast China Disease Control and Prevention Vaccine Consumption Share by End-Users in 2021

    • Figure Northeast China Disease Control and Prevention Vaccine Consumption Share by End-Users in 2027

    • Table Southwest China Disease Control and Prevention Vaccine Consumption by Types from 2016 to 2027

    • Table Southwest China Disease Control and Prevention Vaccine Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Disease Control and Prevention Vaccine Consumption Share by Types in 2016

    • Figure Southwest China Disease Control and Prevention Vaccine Consumption Share by Types in 2021

    • Figure Southwest China Disease Control and Prevention Vaccine Consumption Share by Types in 2027

    • Table Southwest China Disease Control and Prevention Vaccine Consumption by End-Users from 2016 to 2027

    • Table Southwest China Disease Control and Prevention Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Disease Control and Prevention Vaccine Consumption Share by End-Users in 2016

    • Figure Southwest China Disease Control and Prevention Vaccine Consumption Share by End-Users in 2021

    • Figure Southwest China Disease Control and Prevention Vaccine Consumption Share by End-Users in 2027

    • Table Northwest China Disease Control and Prevention Vaccine Consumption by Types from 2016 to 2027

    • Table Northwest China Disease Control and Prevention Vaccine Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Disease Control and Prevention Vaccine Consumption Share by Types in 2016

    • Figure Northwest China Disease Control and Prevention Vaccine Consumption Share by Types in 2021

    • Figure Northwest China Disease Control and Prevention Vaccine Consumption Share by Types in 2027

    • Table Northwest China Disease Control and Prevention Vaccine Consumption by End-Users from 2016 to 2027

    • Table Northwest China Disease Control and Prevention Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Disease Control and Prevention Vaccine Consumption Share by End-Users in 2016

    • Figure Northwest China Disease Control and Prevention Vaccine Consumption Share by End-Users in 2021

    • Figure Northwest China Disease Control and Prevention Vaccine Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of AstraZeneca PLC

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca PLC

    • Figure Sales and Growth Rate Analysis of AstraZeneca PLC

    • Figure Revenue and Market Share Analysis of AstraZeneca PLC

    • Table Product and Service Introduction of AstraZeneca PLC

    • Table Company Profile and Development Status of Astellas Pharma Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma Inc

    • Figure Sales and Growth Rate Analysis of Astellas Pharma Inc

    • Figure Revenue and Market Share Analysis of Astellas Pharma Inc

    • Table Product and Service Introduction of Astellas Pharma Inc

    • Table Company Profile and Development Status of Sinovac Biotech Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sinovac Biotech Ltd

    • Figure Sales and Growth Rate Analysis of Sinovac Biotech Ltd

    • Figure Revenue and Market Share Analysis of Sinovac Biotech Ltd

    • Table Product and Service Introduction of Sinovac Biotech Ltd

    • Table Company Profile and Development Status of Daiichi Sankyo

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daiichi Sankyo

    • Figure Sales and Growth Rate Analysis of Daiichi Sankyo

    • Figure Revenue and Market Share Analysis of Daiichi Sankyo

    • Table Product and Service Introduction of Daiichi Sankyo

    • Table Company Profile and Development Status of GSK

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK

    • Figure Sales and Growth Rate Analysis of GSK

    • Figure Revenue and Market Share Analysis of GSK

    • Table Product and Service Introduction of GSK


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.